TradingView
warrenhochfeld
2 de Nov. de 2017 20:44
Dynavax breakout ahead of Heplisav approval
Largo
NASDAQ:DVAX
60
Dynavax Technologies Corporation
NASDAQ
Descripción
⋅
2 de Nov. de 2017 20:44
Start of final bull run ahead of 9th November FDA announcement of Heplisav approval
$25-$30 price projection
Trend Analysis
Beyond Technical Analysis
biotech
Más